Post-chemotherapy cognitive impairment: Difference between revisions

	Post-chemotherapy cognitive impairment Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Post-chemotherapy cognitive impairment from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Post-chemotherapy cognitive impairment On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Post-chemotherapy cognitive impairment All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Post-chemotherapy cognitive impairment
CDC on Post-chemotherapy cognitive impairment
Post-chemotherapy cognitive impairment in the news
Blogs on Post-chemotherapy cognitive impairment
Directions to Hospitals Treating Post-chemotherapy cognitive impairment
Risk calculators and risk factors for Post-chemotherapy cognitive impairment

VisualWikitext

Revision as of 16:04, 18 August 2015

For patient information on this page, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: chemotherapy-induced cognitive dysfunction, chemo brain, chemo fog

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Post-chemotherapy cognitive impairment from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Future or Investigational Therapies

Case Studies

Case#1

External links

[2]

Template:WH Template:WS

@@ Line 33: / Line 33: @@
 ==Case Studies==
 [[Post-chemotherapy cognitive impairment case study one|Case#1]]
-== References ==
-{{reflist|2}}
-* Tannock IF, Ahles TA, Ganz PA, Van Dam FS. Cognitive impairment associated with chemotherapy for cancer: report of a workshop. ''J Clin Oncol'' 2004;22:2233-9. PMID 15169812.
-* Schagen SB, Muller MJ, Boogerd W, Mellenbergh GJ, van Dam FS. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. ''J Natl Cancer Inst.'' 2006 Dec 6;98(23):1742-5. PMID 17148777
-* Inagaki M et al. Smaller Regional Volumes of Brain Gray and White Matter Demonstrated in Breast Cancer Survivors Exposed to Adjuvant Chemotherapy. ''Cancer.'' DOI 10.1002/cncr.22368. PMID 17131349
-* Silverman DH, Dy CJ, Castellon SA, Lai J, Pio BS, Abraham L, Waddell K, Petersen L, Phelps ME, Ganz PA. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat. 2006 Sep 29; [Epub ahead of print]
-* Inagaki M, Yoshikawa E, Matsuoka Y, Sugawara Y, Nakano T, Akechi T, Wada N, Imoto S, Murakami K, Uchitomi Y. Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer. 2007 Jan 1;109(1):146-56.
-* Posit Science Press Release. “Study on Non-Invasive Therapy for “’Chemobrain.’” [http://www.positscience.com/newsroom/press_releases/pr/110606.php 2006 Nov 6].
 == External links ==
 * [http://bfc.positscience.com/concerns/chemobrain.php What Is Chemobrain?]

Post-chemotherapy cognitive impairment: Difference between revisions

Revision as of 16:04, 18 August 2015

Diagnosis

Treatment

Case Studies

External links

Navigation menu